32.31BMarket Cap
67.69P/E TTM
Beigene Ltd's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Beigene Ltd is 5.88, ranking 355 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 67.69, which is 806.63% below the recent high of 613.74 and 408.77% above the recent low of -209.02.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.